EU approves Bristol-Myers diabetes drug
-
- Share:
-
-
-
-
-
-
Reach -
Credibility
-
Related Allvoices Contributions
-
herbs against 2 nd type diabetes,how long use a infusion?
By: agrimonia
my age is 58 y.old and i have diabetes 2 nd type.use remedies,do diet,search herbs in my disease,in one news is reported about alehoof helps low sugar. Herbs use in that type diabetes,like additional,they use with diet,remedies with your dr. Stabilizates level sugar is helps leafs blueberry,strawberry forest,young oats green sewing,burdock,...
about 1 month ago
-
Desire Drug for Women – Coming Soon
By: dustgeer
German drugmakers working on new desire drug for women hoping to prove disinterest in sex is a legitimate medical condition. Anyone who has ever stayed up late has suffered through the assault of commercials for Extenze or Smiling Bob donning a Santa suit with a long line of ladies waiting to tell him how naughty they’ve been now that ...
15 days ago
- News Source: The Day | about 1 month agoDrugmaker Bristol-Myers Squibb Co. said Monday that its new diabetes drug, Onglyza, has been approved for sale in the European Union's 27 countries. That means Onglyza will compete with Merck & Co.'s blockbuster diabetes drug Januvia both in the EU...
- News Source: Uinta County News | about 1 month agoCombinatoRx Inc. said Monday its development partner Fovea Pharmaceuticals may be acquired by French drugmaker Sanofi-Aventis. CombinatoRx and Fovea are working together on the drug candidate Prednisporin, which is intended to treat persistent...
- News Source: Fox News | about 1 month agoEuropean Union regulators have approved AstraZeneca plc and Bristol-Myers Squibb's diabetes drug Onglyza, the companies said Monday. The product, also known as saxagliptin, is used to treat type 2 diabetes. Onglyza, which was approved by U.S.
- News Source: The News Journal | about 1 month agoDrugmaker Bristol-Myers Squibb Co. says its new diabetes drugs, Onglyza, has been approved for sale in the European Union's 27 countries. That means Onglyza will compete with Merck's blockbuster diabetes drug Januvia both in the EU and in the United...
- Blog Source: blog.taragana.comBristol-Myers gets EU approval for diabetes drugNEW YORK — Drugmaker Bristol-Myers Squibb Co. says its new diabetes drugs, Onglyza, has been approved for sale in the European Union's 27 countries.
- Blog Source: www.dbtechno.comEU Approves Onglyza for Diabetes Patients. October 5, 2009. The European Commission has approved a new diabetes drug manufactured by AstraZeneca and Bristol Myers Squibb Boston (DbTechNo) - The European Commission has approved a new ...
-
Image Source: www.biojobblog.com -
Image Source: www.diseaseproof.com -
Image Source: asp.cumc.columbia.edu -
Image Source: msnbcmedia.msn.com -
Image Source: media.cnbc.com
- Video Source: www.truveo.com
- Video Source: www.truveo.com
- Video Source: xml.truveo.com
- Video Source: youtube.com
Cell phones use report code: Related Allvoices Reports
Site Links
Site Topics
Contributions
- Report Your News
- Add your voice and contribute via your cellphone - check out how to Report News via Your Cellphone
- Blog Widget
- Widget for Blog Owner
